Specialty Clinical Research of St. Louis — St Louis, Missouri

Specialty Clinical Research of St. Louis is a clinical research site located in St Louis, Missouri, United States 63141.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Specialty Clinical Research of St. Louis has participated in 10 clinical trials with 9 currently active.

Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-muscle Invasive Bladder Cancer, Non Muscle Invasive Bladder Cancer.

Sponsors: Dendreon, ImmunityBio, Inc., CG Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Specialty Clinical Research of St. Louis?

Specialty Clinical Research of St. Louis has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Specialty Clinical Research of St. Louis conducted?

Specialty Clinical Research of St. Louis has 10 clinical trials on record, with 9 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-muscle Invasive Bladder Cancer, Non Muscle Invasive Bladder Cancer.

Is Specialty Clinical Research of St. Louis accredited by Crixeo Health?

Yes — Specialty Clinical Research of St. Louis holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Specialty Clinical Research of St. Louis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.